ENTX
NASDAQ · Biotechnology
Entera Bio Ltd
$2.89
+0.02 (+0.70%)
Open$2.85
Previous Close$2.87
Day High$2.92
Day Low$2.75
52W High$4.20
52W Low$0.91
Volume—
Avg Volume581.7K
Market Cap493.45M
P/E Ratio—
EPS$-0.26
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,407.6% upside
Current
$2.89
$2.89
Target
$43.57
$43.57
$34.30
$43.57 avg
$49.66
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 153.7K | 223.9K | 9.20M |
| Net Income | -42,276,562 | -55,448,711 | -2,830,498 |
| Profit Margin | -27,235.7% | -25,873.9% | -30.8% |
| EBITDA | -42,498,531 | -58,836,497 | -2,581,372 |
| Free Cash Flow | — | — | -3,568,526 |
| Rev Growth | -31.4% | -31.4% | +9.2% |
| Debt/Equity | — | — | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |